InsidersTradesSigma
Total declarations
Companies
▲ Purchases (19 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
19
Disclosed sells
15
T+90 hit rate
50%
T+90 mean return
+48.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Kreis Leslie W., Director. Director active across 5 companies, notably Lantern Pharma Inc.. Cumulatively, 45 filings have been logged. Split: 19 buys · 15 sells. Total volume traded: €2.5m. Activity tracked since 16 August 2022. The latest transaction was disclosed on 27 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations45 total
71,428 shares@ US$7.0050.0% of flowCommon StockSEC:0001104659-25-063992
Ideal exit: 24 Mar 2026 (T+270)
71,428 shares@ US$7.000.68% mcap50.0% of flowCommon StockSEC:0001104659-25-063992:0
Ideal exit: 24 Mar 2026 (T+270)
34,000 shares0Common StockSEC:0001104659-25-061242
34,000 shares0Common StockSEC:0001104659-25-061242:0
3 shares@ US$3.400.0% of flowCommon StockSEC:0001104659-25-059091
3 shares@ US$3.400.0000% mcap0.0% of flowCommon StockSEC:0001104659-25-059091:0
7,206 shares@ US$3.090.0% of flowCommon StockSEC:0001104659-25-059526
7,206 shares@ US$3.090.048% mcap0.0% of flowCommon StockSEC:0001104659-25-059526:0
5,314 shares@ US$8.004.3% of flowCommon StockSEC:0001104659-24-091370:0
884,427 sharesCommon StockSEC:0001104659-24-089819:0
8,500 shares0Common StockSEC:0001104659-24-070573:0
930 shares@ US$6.250.8% of flowCommon StockSEC:0001104659-24-065619:0
1,859 shares@ US$6.331.5% of flowCommon StockSEC:0001104659-24-065619:1
6,944 shares@ US$6.255.7% of flowCommon StockSEC:0001104659-24-065619:2
13,888 shares@ US$6.3311.5% of flowCommon StockSEC:0001104659-24-065619:3
2,126 shares@ US$6.251.7% of flowCommon StockSEC:0001104659-24-065619:4
4,253 shares@ US$6.333.5% of flowCommon StockSEC:0001104659-24-065619:5
4,649 shares@ US$4.402.7% of flowCommon StockSEC:0001104659-24-029533:0
7,347 shares@ US$3.133.0% of flowCommon StockSEC:0001104659-24-005238:0
53,640 shares@ US$3.4423.8% of flowCommon StockSEC:0001104659-23-122539:0
500,095 shares@ US$1.0564.8% of flowCommon StockSEC:0001104659-23-116871:0
77,953 sharesConvertible NotesSEC:0001104659-23-074425:0
6,000 shares0Common StockSEC:0001104659-23-070933:0
9,214 shares@ US$2.47883.1% of flowCommon StockSEC:0001104659-22-126433:0
Ideal exit: 8 Sept 2023 (T+270)
57,052 shares@ US$2.478819.1% of flowCommon StockSEC:0001104659-22-126433:1
Ideal exit: 8 Sept 2023 (T+270)
25 of 45 declarations
About Kreis Leslie W.
Kreis Leslie W. is a Director at Lantern Pharma Inc., COGNITION THERAPEUTICS INC, and ACTUATE THERAPEUTICS, INC. As a board member, he contributes to shaping strategy and overseeing the performance of these companies. Leslie brings valuable expertise in biotechnology and therapeutic research.
